BEGIN:VCALENDAR
PRODID:-//eluceo/ical//2.0/EN
VERSION:2.0
CALSCALE:GREGORIAN
BEGIN:VEVENT
UID:3491466733e62f28cf7f93e9d5b2cb9e
DTSTAMP:20240504T094140Z
SUMMARY:The Future Challenges of the Biotech Industry and Life Sciences 
DESCRIPTION: \n\nPlease join us on Thursday May 5th from 12pm-1:30pm in Mal
 vern for\nanother Executive Business Briefing topic. Al Altomari\, Preside
 nt and\nCEO of Agile Therapeutics\, will discuss “The Future Challenges 
 of\nthe Biotech Industry and Life Sciences”.\n\nAl Altomari is the Presi
 dent and CEO of Agile Therapeutics\, a\nNASD-listed bio-technology firm fo
 cused on the development and\ncommercialization of prescription products f
 or women’s health.\nAltomari a LeBow graduate has more than 30 years of 
 experience in the\npharmaceutical industry with focus on the development a
 nd marketing of\nspecialty pharmaceutical products. Prior to his current a
 ppointment\,\nAl served as the CEO of Barrier Therapeutics\, where he comp
 leted the\nsuccessful sale of the company to Stiefel Laboratories and had 
 senior\nmanagement positions at Johnson & Johnson\, Ortho Neutrogena and O
 rtho\nMcNeil Pharmaceuticals. He has served on the board of directors of\n
 several companies including Auxilium Inc\, Dusa Pharmaceuticals and\nNitri
 c Bio Therapeutics. He was recognized by PharmaVoice magazine as\none of t
 he Top 100 Most Inspirational and Influential Leaders in the\nLife Science
 s and he chairs the Pharmaceutical MBA Advisory Council at\nDrexel’s LeB
 ow College of Business.\n 
DTSTART:20160505T160000Z
DTEND:20160505T173000Z
LOCATION:Great Valley Campus\, 2 West Liberty BLVD\, Malvern \, PA 19355
END:VEVENT
END:VCALENDAR